References
- OoiMHWongSCLewthwaitePCardosaMJSolomonTClinical features, diagnosis, and management of enterovirus 71Lancet Neurol.20109 1097 110510.1016/S1474-4422(10)70209-X
- HuangWCHuangLMLuCYChengALChangLYAtypical hand-foot-mouth disease in children: a hospital-based prospective cohort studyVirol. J.20131020910.1186/1743-422X-10-209
- LaiCCJiangDSWuHMChenHHA dynamic model for the outbreaks of hand, foot, and mouth disease in TaiwanEpidemiol. Infect.201516112
- AngLWEpidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007Ann. Acad. Med.200938106112
- MaoQCoxsackievirus A16: epidemiology, diagnosis, and vaccineHum. Vaccin. Immunother.20141036036710.4161/hv.27087
- ZhuangZCEpidemiological research on hand, foot, and mouth disease in mainland ChinaViruses201576400641110.3390/v7122947
- ChangLYComparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998Pediatr. Infect. Dis. J.1999181092109610.1097/00006454-199912000-00013
- LegayFFatal coxsackievirus A-16 pneumonitis in adultEmerg. Infect. Dis.2007131084108610.3201/eid1307.070295
- WangCYLiLuFWuMHLeeCYHuangLMFatal coxsackievirus A16 infectionPediatr. Infect. Dis. J.20042327527610.1097/01.inf.0000115950.63906.78
- RenJStructures of coxsackievirus A16 capsids with native antigenicity: implications for particle expansion, receptor binding, and immunogenicityJ. Virol.201589105001051110.1128/JVI.01102-15
- NishimuraYHuman P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71Nat. Med.20091579479710.1038/nm.1961
- YamayoshiSScavenger receptor B2 is a cellular receptor for enterovirus 71Nat. Med.20091579880110.1038/nm.1992
- YamayoshiSHuman SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71J. Virol.2012865686569610.1128/JVI.00020-12
- LinLTHsuWCLinCCAntiviral natural products and herbal medicinesJ. Tradit. Complement. Med.20144243510.4103/2225-4110.124335
- HsuWCLimonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entryAntivir. Res.201511813914710.1016/j.antiviral.2015.04.003
- CarneiroBMBatistaMNBragaACNogueiraMLRahalPThe green tea molecule EGCG inhibits Zika virus entryVirology201649621521810.1016/j.virol.2016.06.012
- ZhangWAntiviral effects of two Ganoderma lucidum triterpenoids against enterovirus 71 infectionBiochem. Biophys. Res. Commun.201444930731210.1016/j.bbrc.2014.05.019
- LinLTHydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein-glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell-to-cell spreadJ. Virol.2011854386439810.1128/JVI.01492-10
- LinLTBroad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entryBMC Microbiol.20131318710.1186/1471-2180-13-187
- WangSMEnterovirus 71 infection of monocytes with antibody-dependent enhancementClin. Vaccin. Immunol.2010171517152310.1128/CVI.00108-10
- ZhangXCoxsackievirus A16 utilizes cell surface heparan sulfate glycosaminoglycans as its attachment receptorEmerg. Microbes Infect.2017610.1038/emi.2017.55
- Tai, C. J., Li, C. L., Tai, C. J., Wang, C. K. & Lin, L. T. Early viral entry assays for the identification and evaluation of antiviral compounds. J. Vis. Exp., e53124 (2015).
- ShiJHuangXLiuQHuangZIdentification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16Vaccine2013312130213610.1016/j.vaccine.2013.02.051
- DangMMolecular mechanism of SCARB2-mediated attachment and uncoating of EV71Protein Cell2014569270310.1007/s13238-014-0087-3
- RenJPicornavirus uncoating intermediate captured in atomic detailNat. Commun.2013410.1038/ncomms2889
- WangXA sensor-adaptor mechanism for enterovirus uncoating from structures of EV71Nat. Struct. Mol. Biol.20121942442910.1038/nsmb.2255
- ZhangGIn vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infectionArch. Virol.201215766967910.1007/s00705-011-1222-6
- AritaMWakitaTShimizuHCharacterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivityJ. Gen. Virol.2008892518253010.1099/vir.0.2008/002915-0
- ChongPImmunological and biochemical characterization of coxsackie virus A16 viral particlesPLoS One20127e4997310.1371/journal.pone.0049973
- ChongPLiuCCChowYHChouAHKleinMReview of enterovirus 71 vaccinesClin. Infect. Dis.20156079780310.1093/cid/ciu852
- LiuQA virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challengeVaccine2012306642664810.1016/j.vaccine.2012.08.071
- CaiYActive immunization with a coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infectionVaccine2013312215222110.1016/j.vaccine.2013.03.007
- LiCWangHShihSRChenTCLiMLThe efficacy of viral capsid inhibitors in human enterovirus infection and associated diseasesCurr. Med. Chem.20071484785610.2174/092986707780363032
- De ColibusLStructure elucidation of coxsackievirus A16 in complex with GPP3 informs a systematic review of highly potent capsid binders to enterovirusesPLoS Pathog.201511e100516510.1371/journal.ppat.1005165
- De ColibusLMore-powerful virus inhibitors from structure-based analysis of HEV71 capsid-binding moleculesNat. Struct. Mol. Biol.20142128228810.1038/nsmb.2769
- KhanbabaeeKvan ReeTTannins: classification and definitionNat. Prod. Rep.20011864164910.1039/b101061l
- YoshidaTAmakuraYYoshimuraMStructural features and biological properties of ellagitannins in some plant families of the order MyrtalesInt. J. Mol. Sci.2010117910610.3390/ijms11010079
- PourianfarHRKirkKGrolloLInitial evidence on differences among enterovirus 71, coxsackievirus A16 and coxsackievirus B4 in binding to cell surface heparan sulphateVirusdisease20142527728410.1007/s13337-013-0172-x
- TanCWPohCLSamICChanYFEnterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptorJ. Virol.20138761162010.1128/JVI.02226-12
- SATTJGSModern Mass Spectrometry. Topics in Current Chemistry2003Schalley CASpringer
- KumarPenmetcha K.R.Systematic screening of viral entry inhibitors using surface plasmon resonanceReviews in Medical Virology2017276e195210.1002/rmv.1952
- VeluABBPR-3P0128 inhibits RNA-dependent RNA polymerase elongation and VPg uridylylation activities of Enterovirus 71Antivir. Res.2014112182510.1016/j.antiviral.2014.10.003
- LinTCChienSCChenHFHsuFLTannins and related compounds from Combretaceae plantsChin. Pharm. J.20005212610.1211/0022357001773616
- LinTCNonakaGNishiokaIHoFCTannins and related compounds. CII. Structures of terchebulin, an ellagitannin having a novel tetraphenylcarboxylic acid (terchebulic acid) moiety, and biogenetically related tannins from Terminalia chebula RetzChem. Pharm. Bull.1990383004300810.1248/cpb.38.3004
- LinTCStudy on the tannins and related compounds in the fruit of Terminalia catappa LJ. Chin. Med Pharm. Res199214165174
- JuangLJSheuSJChemical identification of the sources of commercial Fructus ChebulaePhytochem. Anal.20051624625110.1002/pca.823
- JuangLJSheuSJLinTCDetermination of hydrolyzable tannins in the fruit of Terminalia chebula Retz. by high-performance liquid chromatography and capillary electrophoresisJ. Sep. Sci.20042771872410.1002/jssc.200401741
- RenJStructures of coxsackievirus A16 capsids with native antigenicity: implications for particle expansion, receptor binding, and immunogenicityJ. Virol.201589105001051110.1128/JVI.01102-15
- PettersenEFUCSF Chimera--a visualization system for exploratory research and analysisJ. Comput. Chem.2004251605161210.1002/jcc.20084
- LangPTDOCK 6: combining techniques to model RNA-small molecule complexesRNA2009151219123010.1261/rna.1563609
- TrottOOlsonAJAutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJ. Comput. Chem.20103145546119499576